Skip to main content

Britt Lisa P.'s Form 4 filing

Thermo Fisher Scientific Inc. (TMO) · filed Nov 10, 2025

Accession no.
0000097745-25-000161
Filed
Nov 10, 2025
Trade date
Nov 7, 2025
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.84M. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Britt Lisa P.CIK 0001676320Officer (Sr. VP and Chief HR Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 7, 2025Common StockSSaleDisposed−1,750$571.40−$999,95014,144.8Direct
Nov 7, 2025Common StockMOption exerciseAcquired+8,475$253.99+$2,152,565.2522,619.8Direct
Nov 7, 2025Common StockSSaleDisposed−8,475$571.67−$4,844,903.2514,144.8Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 7, 2025Common StockMOption exerciseDisposed−8,475$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)